[Multiple drug resistance in Entamoeba histolytica].
Orozco
Esther
E
Departamento de Patología Experimental, CINVESTAV-IPN, México. esther@mail.cinvestav.mx
López
César
C
Gómez
Consuelo
C
Pérez
David G
DG
Marchat
Laurence
L
Bañuelos
Cecilia
C
Delgadillo
Dulce Ma
DM
Luna Arias
Juan P
JP
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics / Q000502:physiology; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D003001:Cloning, Molecular; D018432:Drug Resistance, Multiple; D004640:Emetine / Q000494:pharmacology; D004748:Entamoeba histolytica / Q000187:drug effects* / Q000235:genetics; D005784:Gene Amplification; D019450:Genes, MDR; D017125:Genes, Protozoan; D010641:Phenotype; D011401:Promoter Regions, Genetic; D020033:Protein Isoforms / Q000235:genetics / Q000502:physiology; D015800:Protozoan Proteins / Q000235:genetics / Q000502:physiology; D014158:Transcription, Genetic
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000981:Antiprotozoal Agents; C459579:EhPgp5 protein, Entamoeba histolytica; D020033:Protein Isoforms; D015800:Protozoan Proteins; D004640:Emetine